NEW YORK, Oct 23 – Agilent Technologies said Monday it would supply custom microarray technology to genomics biomarker company DiaDexus.

DiaDexus will use the arrays for research into the molecular basis for cancer and other diseases. Financial details of the agreement were not disclosed, but the cost of Agilent’s arrays range from less than $500 to $1,000 per array.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.